Cogniss partners with Cambridge-based venture capital investor, Start Codon

Cogniss is pleased to announce a partnership with Start Codon, a Cambridge-based venture capital investor and venture builder for early-stage healthcare and life science start-ups. 

Start Codon provides selected companies with a unique combination of funding, facilities and mentoring to support their development and success. They are the third most successful university innovation ecosystem in the world.

This partnership will provide Start Codon’s portfolio of entrepreneurs with access to the Cogniss platform, helping to fast-track the development and commercialization of their innovations. 

Start Codon’s Co-Founder and CEO Dr. Jason Mellad said: “It’s great to partner with a company whose mission aligns so much with ours. Both Start Codon and Cogniss aim to drive the next generation of healthcare, empower innovators and address health inequalities.” 

Cogniss’s Founding CEO Leon Young said: “It will be exciting to see how Start Codon’s entrepreneurs and scientists use the Cogniss platform to create and commercialize their novel ideas and discoveries. 

Partnering with world-leading innovators such as Start Codon is why we established our global headquarters in Cambridge and I look forward to the impact these collaborations will have.”